|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Current assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash and short-term deposits | |||||||||||||||
| Trade accounts receivable and accrued income | |||||||||||||||
| Amounts due from related parties | |||||||||||||||
| Current assets held for sale | |||||||||||||||
| Current portion of net investment in sales-type lease | |||||||||||||||
| Other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Non-current assets | |||||||||||||||
| Restricted cash | |||||||||||||||
| Equity method investments | |||||||||||||||
| Assets under development | |||||||||||||||
| Vessels and equipment, net | |||||||||||||||
| Net investment in sales-type leases | |||||||||||||||
| Intangible assets | |||||||||||||||
| Non-current amounts due from related parties | |||||||||||||||
| Other non-current assets | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||
| Current liabilities | |||||||||||||||
| Current portion of long-term debt | |||||||||||||||
| Current portion of long-term debt and short-term debt | |||||||||||||||
| Trade accounts payable (including related party of $3.0 million in 2025) | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Current liabilities held for sale | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Non-current liabilities | |||||||||||||||
| Long-term debt | |||||||||||||||
| Other non-current liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| EQUITY | |||||||||||||||
| Share capital 101,319,440 common shares of $1.00 each issued and outstanding (2024: 104,534,703) | |||||||||||||||
| Treasury Shares | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Contributed surplus | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Non-controlling interests | |||||||||||||||
| Total equity | |||||||||||||||
| Total liabilities and equity | |||||||||||||||
Loading...